GLP-1 and Vitamin D Levels Effects on Diabetes
Glucagon-like peptide-1 (GLP-1) medications have revolutionized the treatment of type 2 diabetes and obesity. However, recent studies have shown that these medications can lead to nutritional deficiencies, particularly in vitamin D, iron, and B vitamins. In this article, we will explore the relationship between GLP-1 and vitamin D levels effects on diabetes and discuss the implications for patients taking these medications.
GLP-1 Medications and Nutritional Deficiencies
GLP-1 medications stimulate insulin secretion, reduce appetite, and improve glycemic control. However, they can also lead to nutritional deficiencies due to their effects on nutrient absorption and utilization. A 2026 review of six studies found that people with diabetes or obesity taking GLP-1 medications were prone to developing nutrient deficiencies, particularly in vitamin D, iron, and B vitamins.
The Role of Vitamin D in Diabetes
Certain research suggests that adequate vitamin D levels may enhance the glucose-lowering effects of GLP-1 medications by independently improving pancreatic beta-cell function and insulin secretion. Vitamin D also plays a crucial role in renal, endothelial, and cardiovascular protection. Therefore, monitoring vitamin D levels is essential for patients taking GLP-1 medications, particularly those with diabetes.
